Biomarin Pharmaceutical Financials

Values in thousands	2025-09-30	2025-06-30	2025-03-31	2024-12-31
Revenue	$874,565	$825,410	$745,145	$747,313
Gross Profit	579,470	675,320	593,587	611,174
EBITDA	36,161	319,110	263,021	195,496
EBIT	15,723	300,547	240,952	171,889
Net Income	-46,573	240,532	185,686	124,943
Net Change In Cash	874,565	825,410	745,145	747,313
Free Cash Flow	58,922	168,170	157,626	165,328
Cash	1,311,679	1,213,816	1,048,803	942,842
Basic Shares	197,394	196,643	196,474	196,581

Values in thousands	2025-12-31	2024-12-31	2023-12-31	2022-12-31
Revenue	$3,221,253	$2,853,915	$2,419,226	$2,096,039
Gross Profit	2,484,425	2,273,680	1,887,164	1,593,016
EBITDA	613,034	650,528	306,773	265,359
EBIT	533,477	554,102	202,387	163,390
Net Income	348,901	426,859	167,645	141,561
Net Change In Cash	3,221,253	2,853,915	2,419,226	2,096,039
Free Cash Flow	724,956	475,423	62,568	54,943
Cash	1,311,679	942,842	755,127	724,531
Basic Shares	197,394	196,708	191,595	188,963